Financial Tearsheet






Financial Tearsheet

Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

News Releases

14 May 19
Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement
Cronos Group and MediPharm Labs Enter Additional Multi-Year Tolling Arrangement  TORONTO , May 14, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), is pleased to announce that it has entered into a multi-year supply agreement with
09 May 19
Cronos Group Inc. Announces First Quarter 2019 Results
Cronos Group Closes C$2.4 Billion Strategic Investment from Altria Group Cronos Group Establishes Cronos Device Labs , a State-of-the-Art Vaporizer R&D Initiative NatuEra Receives License to Cultivate Psychoactive Cannabis in Colombia Spinach™ Partners with Arrive Alive DRIVE SOBER® Cronos Group
07 May 19
Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel
Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO , May 07, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it is expanding its global infrastructure

SEC Filings

Filing date Description

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Events

07 December 2018 at 8:30 AM EST
Strategic Partnership with Altria Conference Call
13 November 2018 at 8:30 AM EST
Third Quarter 2018 Earnings Conference Call
14 August 2018 at 8:00 AM EDT
Second Quarter 2018 Earnings Conference Call